ロード中...

The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model

BACKGROUND: Tumor necrosis factor (TNF) antagonists [e.g., TNF soluble receptor (TNFsr)] improved survival in preclinical but not clinical sepsis trials. However fluid support—itself beneficial—is standard clinically but rarely employed in pre-clinical sepsis models. We hypothesized that these thera...

詳細記述

保存先:
書誌詳細
主要な著者: Qiu, Ping, Li, Yan, Ding, Yi, Weng, Jia, Banks, Steven M., Kern, Steven, Fitz, Yvonne, Suffredini, Anthony F., Eichacker, Peter Q., Cui, Xizhong
フォーマット: Artigo
言語:Inglês
出版事項: 2011
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3523295/
https://ncbi.nlm.nih.gov/pubmed/21922303
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00134-011-2324-z
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!